(Q43062314)
Statements
A phase I study of foretinib, a multi-targeted inhibitor of c-Met and vascular endothelial growth factor receptor 2 (English)
Joseph Paul Eder
Geoffrey I Shapiro
Andrew X Zhu
Dale Miles
Harold Keer
Belinda Cancilla
Felix Chu
Suzanne Hitchcock-Bryan
Laurie Sherman
Elisabeth I Heath
Scott A Boerner
Patricia M LoRusso